Studying lung cancer tissue and blood for DNA changes
Part of Cancer, Lungs & breathing clinical trials.
This study looks at lung cancer tumor samples and blood to find DNA changes (gene changes) that may be driving the cancer. The results could help researchers better understand lung cancer and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lung cancer confirmed by a pathology test (tumor sample or cell test).
- You may be able to provide a tumor tissue sample (from a biopsy or surgery).
- You may be asked to provide blood samples.
- You may have used an EGFR inhibitor before, and that can still be allowed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at DNA from blood samples and lung tumor tissue in people newly diagnosed with primary lung cancer. The goal is to learn more about the cancer’s biology and possibly guide better future care.
This study looks at genetic (DNA) and molecular (cell-level) information related to lung cancer to better understand the disease. You may be invited if you have a confirmed primary lung cancer diagnosis, or if you are healthy with no cancer.
This study looks at gene-related information from a lung tumor sample and pairs it with special imaging to better understand non-small cell lung cancer. If you have a confirmed diagnosis and the right samples/tests, this may help researchers match patients to the most useful information for planning treatment.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.